Electronic Cigarettes and Nicotine Pouches for Smoking Cessation
NCT05715164 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 600
Last updated 2023-02-06
Summary
Pakistan is one of the most vulnerable low- and middle-income countries with 29 million adult active tobacco users. Smoking cessation services are lacking as the tobacco control initiatives have largely failed to address the smoking endemic. Over the last five years, Pakistan has witnessed the use of innovative tobacco harm reduction such as e-cigarettes, nicotine pouches, and non-nicotine replacement therapies (non-NRTs). However, their use remains limited.
THR products are imported legally as consumer goods and are taxable. The lack of sufficient data for THR and its application is a challenge in gauging their effectiveness in assisting smokers to quit combustible smoking. Evidence-based studies on e-cigarettes and other nicotine products are required to gauge the effectiveness of e-cigarettes and nicotine pouches as smoking cessation aids.
Keeping in view the study objectives, a sample size of 600 participants will be sufficient to assess the effectiveness of e-cigarettes and nicotine pouches for smoking cessation in Pakistan. Of these, 200 participants each will receive e-cigarettes and nicotine pouches along with basic care counseling, while the remaining 200 participants will only receive basic care counseling for 48 weeks. The association of participants' characteristics with smoking and health status will be based on bivariate and multivariate analysis. The simple t-test and variance analysis will assess the differences in intervention indicators between the control and treatment groups. For the inferential analysis, the average treatment impact of the treatments will find using quasi-experimental techniques such as difference in difference (DID) or Propensity Score Matching (PMS).
This study will be evaluated participants at baseline, after their self-decided "quit date,". The follow-up will be a survey every 12 weeks. Results may inform the public, decision-makers, and researchers about the use of e-cigarettes and nicotine pouches helping smokers to quit smoking or switch to less harmful alternatives in the short- and medium-term periods.
Conditions
- Role of Tobacco Harm Reduction in Smoking Cessation
- Efficiency and Efficacy of E-cigarettes and Nicotine Pouches
- Adverse Effect of E-cigarettes and Nicotine Pouches
Interventions
- DEVICE
-
E-cigarettes device plus liquid
The four basic care counseling sessions will be held over the course of 48 weeks with the supply of e-cigarettes and liquid. Every 12 weeks, a standard care counseling session will be offered, and it will be followed by a study visit to track any alterations in the user's physical or mental health as well as any side effects from using e-cigarettes.
- DRUG
-
Nicotine Pouches
The four basic care counseling sessions will be held over the course of 48 weeks with a supply of nicotine pouches. Every 12 weeks, a standard care counseling session will be offered, and it will be followed by a study visit to track any alterations in the user's physical or mental health as well as any side effects from using nicotine pouches.
- OTHER
-
Basic care counseling about smoking cessation
The four basic care counseling sessions will be held over the course of 48 weeks. Every 12 weeks, a standard care counseling session will be offered, and it will be followed by a study visit to track any alterations in the user's physical or mental health.
Sponsors & Collaborators
-
Foundation for a Smoke Free World INC
collaborator OTHER -
Alternative Research Initiative
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-12-31
- Primary Completion
- 2024-04-30
- Completion
- 2025-04-30
Countries
- Pakistan
Study Locations
More Related Trials
-
Clinical Pharmacology of Electronic Cigarettes
NCT02470754 ·Status: COMPLETED ·Phase: NA
-
Noncombustible Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette Smokers
NCT06372899 ·Status: RECRUITING ·Phase: NA
-
Exploring the Long-term Cardiovascular Effects of Vaping
NCT05757934 ·Status: ACTIVE_NOT_RECRUITING
-
Interest in Smokeless Tobacco Product as a Substitution for Cigarettes in Current Smokers
NCT01800500 ·Status: TERMINATED ·Phase: NA
-
Epidemiology and Acute Oral Effects Electronic Cigarette
NCT03011710 ·Status: COMPLETED ·Phase: NA
-
Nicotine Pharmacokinetic in Blood and Analysis of Exhaled Breath After E-cigarette Smoking.
NCT03573154 ·Status: UNKNOWN ·Phase: NA
-
High Cessation Rates in Smokers Using Personal Vaporizers
NCT02124200 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of E-cigs vs Pouches on Cigarette Smoking and Addiction
NCT06077240 ·Status: RECRUITING ·Phase: NA
-
A Structured Protocol to Evaluate Efficacy and Safety of a Popular Electronic Nicotine Delivery Device (E-Cigarette) Efficacy and Safety of a Popular Electronic Nicotine Delivery Device (E-Cigarette)
NCT01188239 ·Status: COMPLETED
-
Very Low Nicotine Content Cigarettes and E-Cigarettes in Promoting Smoking Cessation in Daily and Intermittent Cigarette Smokers
NCT02964182 ·Status: COMPLETED ·Phase: NA
-
Electronic Cigarette Use and Quitting in Youth
NCT02949648 ·Status: COMPLETED
-
The Role of Flavor in the Substitutability of E-cigarettes for Combustible Cigarettes Among Persistent Smokers
NCT06264154 ·Status: RECRUITING ·Phase: NA
-
A Study to Evaluate the Safety of Electronic Vapor Products for 2 Years
NCT02143310 ·Status: COMPLETED ·Phase: NA
-
A Trial of E-cigarettes in Current Cigarette Smokers
NCT02357173 ·Status: COMPLETED ·Phase: NA
-
Acute Health Effects of Short-term Use of E-cigarettes on Pulmonary and Cardiovascular System
NCT03742700 ·Status: COMPLETED ·Phase: NA
-
Using ANDS to Reduce Harm for Low SES Cigarette Smokers
NCT05327439 ·Status: UNKNOWN ·Phase: NA
-
Acute Response to Cigarette and E-cigarette Smoking Assesed in Exhaled Breath Condensate in Healthy Smokers of Traditional and E-cigarettes
NCT03153228 ·Status: UNKNOWN
-
E-cigarette vs. Nicotine Inhaler Comparisons
NCT02294617 ·Status: COMPLETED ·Phase: NA
-
Nicotine Flux, a Potentially Powerful Tool for Regulating Nicotine Delivery From Electronic Cigarettes
NCT05706701 ·Status: COMPLETED ·Phase: NA
-
Toxins and Delivery in e-Cigarette Users
NCT01714778 ·Status: COMPLETED
-
Comparison of Electronic Cigarettes and Tobacco Cigarettes on Cardiovascular Function and Oxidative Stress
NCT03036644 ·Status: COMPLETED ·Phase: NA
-
The ESTxENDS Trial- Substudy on the Effect on Toxins From Using Electronic Nicotine Delivery Systems (ENDS/Vaporizer/E-cig)
NCT03612544 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of an Electronic Nicotine Delivery Device (E-Cigarette) Without Nicotine Cartridges
NCT01194583 ·Status: COMPLETED
-
Acute Cardiorespiratory Effects of E-cigarette Inhalation
NCT02899234 ·Status: COMPLETED ·Phase: NA
-
Understanding the Impact of Cartridge-Based Electronic Cigarettes and Generated Aerosols on Cardiopulmonary Health
NCT05199480 ·Status: COMPLETED ·Phase: EARLY_PHASE1